Astrazeneca Pharma India Ltd
ASTRAZENAstrazeneca Pharma India Ltd
ASTRAZENPrice Chart
How to use scorecard? Learn more
Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
94.12 | 22.28 | 0.31% |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
51.33 | 5.84 | 0.57% |
Forecast & Ratings
Detailed ForecastPrice
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
AstraZeneca Pharma India Limited is a biopharmaceutical company engaged in the discovery, development and commercialization of medicines for core areas of healthcare.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Zydus Lifesciences Ltd
Mankind Pharma Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Revenue Forecast
Earnings Per Share Forecast
Income
Balance Sheet
Cash Flow
Income Statement
Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 522.92 | 570.50 | 558.10 | 583.25 | 744.58 | 844.80 | 826.40 | 820.36 | 1,029.07 | 1,247.58 | ||||||||||
Raw Materials | 194.06 | 193.65 | 155.96 | 231.52 | 232.51 | 344.44 | 292.00 | 297.49 | 408.84 | 1,042.33 | ||||||||||
Power & Fuel Cost | 8.51 | 7.43 | 7.68 | 8.30 | 8.27 | 7.72 | 7.37 | 8.10 | 5.54 | |||||||||||
Employee Cost | 159.84 | 169.35 | 162.04 | 150.39 | 197.40 | 216.70 | 219.54 | 230.21 | 259.10 | |||||||||||
Selling & Administrative Expenses | 141.54 | 154.91 | 144.27 | 168.54 | 198.14 | 157.18 | 129.72 | 145.09 | 191.64 | |||||||||||
Operating & Other expenses | 24.53 | 21.98 | 36.82 | -34.04 | 20.67 | -14.93 | 29.46 | 38.53 | 12.96 | |||||||||||
EBITDA | -5.56 | 23.18 | 51.33 | 58.54 | 87.59 | 133.69 | 148.31 | 100.94 | 150.99 | 205.25 | ||||||||||
Depreciation/Amortization | 15.28 | 17.43 | 15.83 | 14.74 | 14.92 | 18.58 | 20.13 | 16.95 | 16.26 | 15.42 | ||||||||||
PBIT | -20.84 | 5.75 | 35.50 | 43.80 | 72.67 | 115.11 | 128.18 | 83.99 | 134.73 | 189.83 | ||||||||||
Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.14 | 1.09 | 0.95 | 0.63 | 1.35 | ||||||||||
PBT | -20.84 | 5.75 | 35.50 | 43.80 | 72.67 | 113.97 | 127.09 | 83.04 | 134.10 | 188.48 | ||||||||||
Taxes & Other Items | 0.00 | 0.50 | 15.45 | 17.89 | 18.22 | 41.76 | 33.79 | 21.44 | 34.81 | 49.15 | ||||||||||
Net Income | -20.84 | 5.25 | 20.05 | 25.91 | 54.45 | 72.21 | 93.30 | 61.60 | 99.29 | 139.33 | ||||||||||
EPS | -8.34 | 2.10 | 8.02 | 10.36 | 21.78 | 28.88 | 37.32 | 24.64 | 39.72 | 55.73 | ||||||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.00 | 2.00 | 10.00 | 16.00 | 16.00 | ||||||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.03 | 0.05 | 0.41 | 0.40 | 0.29 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Astrazeneca Pharma India Ltd | 132.07 | 22.28 | 0.31% |
Sun Pharmaceutical Industries Ltd | 42.04 | 6.01 | 0.77% |
Cipla Ltd | 38.81 | 4.59 | 0.63% |
Dr Reddy's Laboratories Ltd | 21.99 | 4.26 | 0.67% |
Price Comparison
Compare ASTRAZEN with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Astrazeneca Pharma India Ltd
Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
---|---|---|---|---|
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.6643% | Percentage of the fund’s portfolio invested in the stock 0.76% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 20/218 (+2) |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Plan Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.4534% | Percentage of the fund’s portfolio invested in the stock 1.61% | Change in the portfolio weight of the stock over the last 3 months 1.61% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/59 (+22) |
ICICI PRUDENTIAL INNOVATION FUND DIRECT PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3150% | Percentage of the fund’s portfolio invested in the stock 0.93% | Change in the portfolio weight of the stock over the last 3 months 0.62% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 31/90 (+8) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateJul 14, 2023
Dividend/Share
₹16.00
Ex DateEx Date
Jul 14, 2023
Cash Dividend
Ex DateEx DateJul 7, 2022
Dividend/Share
₹8.00
Ex DateEx Date
Jul 7, 2022
Cash Dividend
Ex DateEx DateAug 18, 2021
Dividend/Share
₹2.00
Ex DateEx Date
Aug 18, 2021
Cash Dividend
Ex DateEx DateAug 20, 2020
Dividend/Share
₹2.00
Ex DateEx Date
Aug 20, 2020
Cash Dividend
Ex DateEx DateAug 20, 2019
Dividend/Share
₹1.00
Ex DateEx Date
Aug 20, 2019
News & Opinions
AstraZeneca Pharma Shares Plunge 14% To One-Month Low After Q3 Profit Dips 46%
2 months ago•Bloomberg Quint
AstraZeneca Pharma India Plans To Sell Bengaluru Manufacturing Plant, Check Details - News18
5 months ago•News18
Gift Nifty signals a tepid start: ITC, Vodafone Idea Q1 results; stocks in F&O ban; TVS Supply IPO & more
8 months ago•Business Today
Stocks in news: ITC, Adani Ports, Tata Steel, Nykaa, Vodafone Idea, HDFC Bank & CarTrade
8 months ago•Business Today
AstraZeneca Pharma shares gain on pediatric drug launch in India
8 months ago•Moneycontrol
Stocks that will see action today: July 25, 2023
9 months ago•The Hindu Businessline
AstraZeneca gets GCGI approval to import heart failure drug
9 months ago•Economic Times
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 12.03%, vs industry avg of 8.36%
Increasing Market Share
Over the last 5 years, market share increased from 0.29% to 0.32%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 30.82%, vs industry avg of 9.82%